Key result
Switching from verapamil to captopril precipitates acute MI in severe hypertension with normal coronary arteries.
Why the study?
Verapamil is an effective antihypertensive with uncommon serious adverse effects, but its withdrawal coinciding with myocardial infarction has not been well described.
Does verapamil withdrawal cause myocardial infarction in patients with severe hypertension?
Case Report (n=1)
Does verapamil withdrawal cause myocardial infarction in patients with severe hypertension?
Verapamil withdrawal may be associated with myocardial infarction in hypertensive patients, possibly due to increased platelet or vascular alpha 2-adrenoreceptor affinity for catecholamines.
Answers are grounded in this paper and cite their sources.
May signal risk with abrupt verapamil withdrawal during antihypertensive switch; hypothesis-generating and leaves causal role in MI open.
Verapamil is an effective and relatively-safe antihypertensive drug. Serious adverse effects are uncommon and mainly have been related to the depression of cardiac contractility and conduction, especially when the drug is combined with beta-blocking agents. We report a case in which myocardial infarction coincided with the introduction of captopril and the withdrawal of verapamil in a previously asymptomatic woman with severe hypertension. Possible mechanisms that involve a verapamil-related increase in platelet and/or vascular alpha 2-adrenoreceptor affinity for catecholamines are discussed.
No takes yet. Share an insight, caveat, or question.
Dimmitt et al. (1988) conducted a case report in Severe hypertension (n=1). Verapamil withdrawal and captopril introduction was evaluated on Myocardial infarction. Verapamil withdrawal and captopril introduction coincided with a myocardial infarction in a previously asymptomatic woman with severe hypertension and a normal coronary angiogram.
Synapse has enriched 10 related papers. Consider them for comparative context: